Volume 132, Issue 2, Pages (February 2007)

Slides:



Advertisements
Similar presentations
Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells Elena Sandalova, Diletta Laccabue, Carolina Boni, Tsunamasa.
Advertisements

Volume 143, Issue 5, Pages (November 2012)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 132, Issue 3, Pages (March 2007)
Volume 152, Issue 4, Pages (March 2017)
SMAD About Hepatitis C Virus Cell Entry and Liver Disease
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Christoph Lübbert, Babett Holler  Gastroenterology 
Spontaneous Self-Expulsion of a Large Stone From the Abdomen
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Volume 154, Issue 3, Pages (February 2018)
How to Critically Read the GI Epidemiology Literature
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Gastroenterology 2011–2016: Looking Back and Forward
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
Unusual Case of an Upset Stomach
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages (March 2018)
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 156, Issue 3, Pages (February 2019)
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 145, Issue 1, Pages (July 2013)
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Efficient Early Drug Development for Ulcerative Colitis
An Unexpected Cause of Intestinal Obstruction in an Uncommon Site
Coffee and Colorectal Cancer: Grounds for Prevention?
Melena and Hyperammonemic Seizures in a Turner Syndrome Patient
Hashem El–Serag, Anna S.F. Lok, David L. Thomas  Gastroenterology 
Volume 133, Issue 2, Pages (August 2007)
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Will There Be a Vaccine to Protect Against the Hepatitis C Virus?
Volume 148, Issue 3, Pages (March 2015)
Immune Quiescence and Hepatitis B Virus: Tolerance Has Its Limits
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
An Unusual Cause of Small Bowel Obstruction
Volume 150, Issue 7, Pages (June 2016)
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 132, Issue 3, Pages (March 2007)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Volume 156, Issue 4, Pages (March 2019)
Volume 156, Issue 6, Pages (May 2019)
Changing of the Guards: 2011–2016 Gastroenterology Team
Electronic Clinical Challenges and Images in GI
Volume 156, Issue 3, Pages (February 2019)
Electronic Clinical Challenges and Images in GI
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 138, Issue 6, Pages (May 2010)
Reinvesting in US Biomedical Research—The Time is Now
Electronic Clinical Challenges and Images in GI
Electronic Clinical Challenges and Images in GI
The Future of Endoscopic Retrograde Cholangiopancreatography
Controversies in Liver Transplantation for Hepatitis C
Amir Klein, Michael J. Bourke  Gastroenterology 
Craig Lammert, Megan Comerford, Joshua Love  Gastroenterology 
Volume 156, Issue 4, Pages (March 2019)
Volume 153, Issue 5, Pages (November 2017)
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Volume 132, Issue 2, Pages 801-805 (February 2007) T and B Cells in Hepatitis C Virus Control: What They Do and When They Fail  Carlo Ferrari  Gastroenterology  Volume 132, Issue 2, Pages 801-805 (February 2007) DOI: 10.1053/j.gastro.2007.01.010 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 HCV can outpace the immune response. The intrinsic replication kinetics of HCV and the intrinsic inhibitory properties of the HCV proteins can provide HCV with an initial survival advantage over the immune system. These early mechanisms can set in motion a series of sequential events that together provide HCV with a high likelihood to evade immune surveillance and to persist. DC, dendritic cell; CTL, cytotoxic T lymphocyte; Th1 and Th2, T helper 1 and T helper 2. Gastroenterology 2007 132, 801-805DOI: (10.1053/j.gastro.2007.01.010) Copyright © 2007 AGA Institute Terms and Conditions